84 related articles for article (PubMed ID: 9151836)
1. Putative alpha-helical structures in the human immunodeficiency virus type 1 Vpu protein and CD4 are involved in binding and degradation of the CD4 molecule.
Tiganos E; Yao XJ; Friborg J; Daniel N; Cohen EA
J Virol; 1997 Jun; 71(6):4452-60. PubMed ID: 9151836
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1.
Ma C; Marassi FM; Jones DH; Straus SK; Bour S; Strebel K; Schubert U; Oblatt-Montal M; Montal M; Opella SJ
Protein Sci; 2002 Mar; 11(3):546-57. PubMed ID: 11847278
[TBL] [Abstract][Full Text] [Related]
3. Insights into the oligomeric structure of the HIV-1 Vpu protein.
Majeed S; Adetuyi O; Borbat PP; Majharul Islam M; Ishola O; Zhao B; Georgieva ER
J Struct Biol; 2023 Mar; 215(1):107943. PubMed ID: 36796461
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpu protein forms stable oligomers in aqueous solution via its transmembrane domain self-association.
Majeed S; Dang L; Islam MM; Ishola O; Borbat PP; Ludtke SJ; Georgieva ER
Sci Rep; 2023 Sep; 13(1):14691. PubMed ID: 37673923
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpu protein forms stable oligomers in aqueous solution via its transmembrane domain self-association.
Majeed S; Dang L; Islam MM; Ishola O; Borbat PP; Ludtke SJ; Georgieva ER
bioRxiv; 2023 Jul; ():. PubMed ID: 37214796
[TBL] [Abstract][Full Text] [Related]
6. Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins.
Ramirez PW; Sharma S; Singh R; Stoneham CA; Vollbrecht T; Guatelli J
Cells; 2019 Sep; 8(9):. PubMed ID: 31480747
[TBL] [Abstract][Full Text] [Related]
7. Endocytic activity of HIV-1 Vpu: Phosphoserine-dependent interactions with clathrin adaptors.
Stoneham CA; Singh R; Jia X; Xiong Y; Guatelli J
Traffic; 2017 Aug; 18(8):545-561. PubMed ID: 28504462
[TBL] [Abstract][Full Text] [Related]
8. Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide.
Deb A; Johnson WA; Kline AP; Scott BJ; Meador LR; Srinivas D; Martin-Garcia JM; Dörner K; Borges CR; Misra R; Hogue BG; Fromme P; Mor TS
PLoS One; 2017; 12(2):e0172529. PubMed ID: 28225803
[TBL] [Abstract][Full Text] [Related]
9. Membrane protein assembly: two cytoplasmic phosphorylated serine sites of Vpu from HIV-1 affect oligomerization.
Chen CP; Lin MH; Chan YT; Chen LC; Ma C; Fischer WB
Sci Rep; 2016 Jun; 6():28866. PubMed ID: 27353136
[TBL] [Abstract][Full Text] [Related]
10. Structural determination of virus protein U from HIV-1 by NMR in membrane environments.
Zhang H; Lin EC; Das BB; Tian Y; Opella SJ
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):3007-3018. PubMed ID: 26362058
[TBL] [Abstract][Full Text] [Related]
11. Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals.
Pickering S; Hué S; Kim EY; Reddy S; Wolinsky SM; Neil SJ
PLoS Pathog; 2014 Jan; 10(1):e1003895. PubMed ID: 24465210
[TBL] [Abstract][Full Text] [Related]
12. Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactions.
Yoshida T; Koyanagi Y; Strebel K
J Virol; 2013 Dec; 87(24):13825-36. PubMed ID: 24109238
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of function of viral channel proteins and implications for drug development.
Fischer WB; Wang YT; Schindler C; Chen CP
Int Rev Cell Mol Biol; 2012; 294():259-321. PubMed ID: 22364876
[TBL] [Abstract][Full Text] [Related]
14. Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.
Xue B; Mizianty MJ; Kurgan L; Uversky VN
Cell Mol Life Sci; 2012 Apr; 69(8):1211-59. PubMed ID: 22033837
[TBL] [Abstract][Full Text] [Related]
15. The T cell receptor triggering apparatus is composed of monovalent or monomeric proteins.
James JR; McColl J; Oliveira MI; Dunne PD; Huang E; Jansson A; Nilsson P; Sleep DL; Gonçalves CM; Morgan SH; Felce JH; Mahen R; Fernandes RA; Carmo AM; Klenerman D; Davis SJ
J Biol Chem; 2011 Sep; 286(37):31993-2001. PubMed ID: 21757710
[TBL] [Abstract][Full Text] [Related]
16. Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach.
Yoshida T; Kao S; Strebel K
Front Microbiol; 2011; 2():35. PubMed ID: 21687426
[TBL] [Abstract][Full Text] [Related]
17. Modulation of HIV-1-host interaction: role of the Vpu accessory protein.
Dubé M; Bego MG; Paquay C; Cohen ÉA
Retrovirology; 2010 Dec; 7():114. PubMed ID: 21176220
[TBL] [Abstract][Full Text] [Related]
18. The Vpu protein: new concepts in virus release and CD4 down-modulation.
Ruiz A; Guatelli JC; Stephens EB
Curr HIV Res; 2010 Apr; 8(3):240-52. PubMed ID: 20201792
[TBL] [Abstract][Full Text] [Related]
19. Identification of amino acids within the second alpha helical domain of the human immunodeficiency virus type 1 Vpu that are critical for preventing CD4 cell surface expression.
Hill MS; Ruiz A; Schmitt K; Stephens EB
Virology; 2010 Feb; 397(1):104-12. PubMed ID: 19944437
[TBL] [Abstract][Full Text] [Related]
20. Viral channel-forming proteins.
Fischer WB; Krüger J
Int Rev Cell Mol Biol; 2009; 275():35-63. PubMed ID: 19491052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
